Reports $25.6 Million in Cash and Marketable Securities as of December 31, 2021, Expected to Support Operations Into Second Half...
YONKERS, N.Y., March 21, 2022 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the...
CAMBRIDGE, Mass., March 21, 2022 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed...
Amarin-Supported Research and Analyses to Be Featured in Six PresentationsDUBLIN, Ireland and BRIDGEWATER, N.J., March 21, 2022 (GLOBE NEWSWIRE) --...
Red Light Holland's licensed subsidiary Scarlette Lillie Sciences and Innovation granted authorization for first ever psilocybin import into St. Vincent...
Vancouver, British Columbia--(Newsfile Corp. - March 21, 2022) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) (the "Company"),...
Toronto, Ontario--(Newsfile Corp. - March 21, 2022) - Lophos Pharmaceuticals Inc., a Canadian psychedelic research company focused on cultivation and...
Bespoke speech recognition technology, Augnito, aids Wellbeing Software with highly accurate Radiology Information System workflows. Scribetech has announced the integration...
STOCKHOLM, SWEDEN / ACCESSWIRE / March 21, 2022 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical...
STOCKHOLM, SWEDEN / ACCESSWIRE / March 21, 2022 / iZafe Group (STO:IZAFE-B)iZafe Group (publ.) hereby announces that the partner Zafe...
GOTHENBURG, SWEDEN / ACCESSWIRE / March 21, 2022 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA)IRLAB (Nasdaq Stockholm: IRLAB A) takes important steps...
FIRST DOSING OF A STUDY PARTICIPANT TRIGGERS MILESTONE PAYMENT OF € 3 M TO EVOTECPHASE II CLINICAL TRIAL INITIATED BY...
Proven Pharmaceutical Sales Professional Brings Big Pharma Experience to Relief's U.S. Expansion ActivitiesGENEVA, SWITZERLAND / ACCESSWIRE / March 21, 2022...
GENEVA, SWITZERLAND / ACCESSWIRE / March 21, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) ("Relief"), announced today that it has...
CAMBRIDGE, MA / ACCESSWIRE / March 21, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics...
BOTHELL, Wash., March 20, 2022 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on...
VANCOUVER, British Columbia, March 19, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN:...
Vancouver, British Columbia--(Newsfile Corp. - March 18, 2022) - Advanced Proteome Therapeutics Corporation (TSXV: APC) (FSE: 0E81) ("APC" or the "Company") announces that,...
KITCHENER, ON / ACCESSWIRE / March 18, 2022 / Cloud DX (TSXV:CDX)(OTCQB:CDXFF), a leading North American provider of virtual care...
Precision medicine initiative leverages innovative technologies and unprecedented 80% diverse participant base to drive new research aiming to support novel...